Detalles de la búsqueda
1.
Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposal.
Lung Cancer
; 191: 107789, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38614068
2.
Changes in the management of chronic thromboembolic pulmonary hypertension over a 10-year period, in a French expert regional competence centre.
Respir Med Res
; 84: 101021, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276770
3.
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC).
Lung Cancer
; 186: 107393, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839252
4.
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer.
J Thorac Oncol
; 18(10): 1408-1415, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217096
5.
Response to Commentary on "Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti-PD(L)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer".
J Thorac Oncol
; 18(10): e114-e115, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758349
Resultados
1 -
5
de 5
1
Próxima >
>>